# Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases

> **NCT04655612** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 5000 (actual)

## Conditions studied

- COVID-19
- SARS-CoV Infection
- Rheumatoid Arthritis
- Spondyloarthritis
- Ankylosing Spondylitis
- Psoriatic Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04655612
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-07-30
- **Target enrollment:** 5000 (ACTUAL)
- **Last updated:** 2021-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04655612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04655612, "Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04655612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*